Illumina, ResMed fall; Broadridge, Humana rise

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:

Illumina Inc., down $19.12 to $208.33.

The genetic testing tools company reported disappointing second-quarter financial results.

Chevron Corp., up 23 cents to $159.85.

Energy companies lagged the broader market as crude oil prices fell.

Freeport-McMoRan Inc., down 5 cents to $31.62.

The copper mining company fell along with prices for the base metal.

ResMed Inc., down 86 cents to $239.99.

The maker of medical products for respiratory disorders warned investors about continued supply chain problems.

Broadridge Financial Solutions Inc., up $13.49 to $183.22.

The technology outsourcing company beat Wall Street's fiscal fourth-quarter financial results.

Johnson & Johnson, down $1.84 to $165.30.

The Band-Aid maker will stop selling baby powder containing talc next year amid lawsuits claiming it caused cancer.

Humana Inc., up $12.81 to $496.88.

The health insurer is buying most of the assets of Inclusa, a provider of long-term care services for older adults in Wisconsin.

Newmont Corp., up $1.25 to $46.55.

The gold producer rose as prices for the precious metal edged higher.

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Broadridge Financial Solutions (BR)
4.5082 of 5 stars
$195.13-0.4%1.64%33.99Hold$206.67
Humana (HUM)
4.9975 of 5 stars
$314.11-4.2%1.13%15.85Hold$454.63
Johnson & Johnson (JNJ)
4.9067 of 5 stars
$148.59-0.6%3.20%9.26Hold$175.86
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: